FDA approves world-first brain modulation device to treat PT

GrayMatters Health has announced that it has received clearance from the US Food and Drug Administration to market its healing product Prism, conceived for treating post-traumatic stress disorder.

Related Keywords

Israel , Talma Hendler , Tel Aviv Sourasky Medical Center , Sagol Brain Institute , Tel Aviv University , Graymatters Health , Prism , Ptsd , Soldiers ,